160 related articles for article (PubMed ID: 10924302)
1. Hospital readmission after transvenous cardioverter/defibrillator implantation; a single centre study.
Korte T; Jung W; Ostermann G; Wolpert C; Spehl S; Esmailzadeh B; Lüderitz B
Eur Heart J; 2000 Jul; 21(14):1186-91. PubMed ID: 10924302
[TBL] [Abstract][Full Text] [Related]
2. Hospital readmission in patients with implantable cardioverter-defibrillators.
Kaźmierczak J; Zielonka J; Rzeuski R; Peregud-Pogorzelska M; Goracy J; Biernawska J; Sulikowski T; Kornacewicz-Jach Z
Kardiol Pol; 2006 Jul; 64(7):684-91; discussion 692-3. PubMed ID: 16886125
[TBL] [Abstract][Full Text] [Related]
3. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
[TBL] [Abstract][Full Text] [Related]
4. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.
Kleemann T; Becker T; Doenges K; Vater M; Senges J; Schneider S; Saggau W; Weisse U; Seidl K
Circulation; 2007 May; 115(19):2474-80. PubMed ID: 17470696
[TBL] [Abstract][Full Text] [Related]
5. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
6. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.
Wichter T; Paul M; Wollmann C; Acil T; Gerdes P; Ashraf O; Tjan TD; Soeparwata R; Block M; Borggrefe M; Scheld HH; Breithardt G; Böcker D
Circulation; 2004 Mar; 109(12):1503-8. PubMed ID: 15007002
[TBL] [Abstract][Full Text] [Related]
7. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
[TBL] [Abstract][Full Text] [Related]
8. ICD: a qualitative study of patient experience the first year after implantation.
Kamphuis HC; Verhoeven NW; Leeuw R; Derksen R; Hauer RN; Winnubst JA
J Clin Nurs; 2004 Nov; 13(8):1008-16. PubMed ID: 15533107
[TBL] [Abstract][Full Text] [Related]
9. Potential role of remote monitoring for scheduled and unscheduled evaluations of patients with an implantable defibrillator.
Heidbüchel H; Lioen P; Foulon S; Huybrechts W; Ector J; Willems R; Ector H
Europace; 2008 Mar; 10(3):351-7. PubMed ID: 18245771
[TBL] [Abstract][Full Text] [Related]
10. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks.
Pedersen SS; van Domburg RT; Theuns DA; Jordaens L; Erdman RA
Am Heart J; 2005 Apr; 149(4):664-9. PubMed ID: 15990750
[TBL] [Abstract][Full Text] [Related]
11. Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: results from the EVADEF cohort study.
Otmani A; Trinquart L; Marijon E; Lavergne T; Waintraub X; Lepillier A; Chatellier G; Le Heuzey JY;
Am Heart J; 2009 Aug; 158(2):230-237.e1. PubMed ID: 19619699
[TBL] [Abstract][Full Text] [Related]
12. Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery.
O'Neill JO; Starling RC; Khaykin Y; McCarthy PM; Young JB; Hail M; Albert NM; Smedira N; Chung MK
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1250-6. PubMed ID: 16256775
[TBL] [Abstract][Full Text] [Related]
13. Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias.
Ypenburg C; van Erven L; Bleeker GB; Bax JJ; Bootsma M; Wijffels MC; van der Wall EE; Schalij MJ
J Am Coll Cardiol; 2006 Aug; 48(3):464-70. PubMed ID: 16875970
[TBL] [Abstract][Full Text] [Related]
14. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP
J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019
[TBL] [Abstract][Full Text] [Related]
15. Effect of first ventricular tachycardia cycle length on rate of ventricular arrhythmia recurrence in patients with implantable cardioverter-defibrillator.
Arya A; Haghjoo M; Nikoo MH; Dehghani MR; Fazelifar AF; Sadr-Ameli MA
J Electrocardiol; 2006 Oct; 39(4):404-8. PubMed ID: 16895771
[TBL] [Abstract][Full Text] [Related]
16. The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003.
Proclemer A; Ghidina M; Cicuttini G; Gregori D; Fioretti PM
Ital Heart J; 2005 Mar; 6(3):272-80. PubMed ID: 15875520
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators.
Kolb C; Deisenhofer I; Schmieder S; Barthel P; Zrenner B; Karch MR; Schmitt C
Pacing Clin Electrophysiol; 2006 Sep; 29(9):946-52. PubMed ID: 16981917
[TBL] [Abstract][Full Text] [Related]
18. Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter-defibrillator.
Serizawa N; Yumino D; Kajimoto K; Tagawa Y; Takagi A; Shoda M; Kasanuki H; Hagiwara N
Am J Cardiol; 2008 Oct; 102(8):1064-8. PubMed ID: 18929710
[TBL] [Abstract][Full Text] [Related]
19. Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07.
Proclemer A; Ghidina M; Gregori D; Facchin D; Rebellato L; Fioretti P; Brignole M
Europace; 2009 Apr; 11(4):465-75. PubMed ID: 19136490
[TBL] [Abstract][Full Text] [Related]
20. Implantable cardioverter-defibrillator lead failure: how weak is the link?
Brinker JA
Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
